5 Best Healthcare Stocks to Buy According to Matthew Halbower’s Pentwater Capital Management
In this article, we discuss the 5 best healthcare stocks to buy according to Matthew Halbower's Pentwater Capital Management.
Karuna Therapeutics Inc. (KRTX)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 974,345 | $123,537 | +13% | 0.49% |
| 2. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 432,543 | $54,842 | +2% | 1.38% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 400,000 | $50,716 | +238% | 0.09% |
| 4. | Farallon Capital Thomas Steyer | 350,000 | $44,377 | -37% | 0.23% |
| 5. | Logos Capital Arsani William | 340,000 | $43,109 | +14% | 5.58% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $129.38 | 47 | Director | 683 | 2022-04-01 | Filing | |
| $106.10 | 1,181 | 108,849 | 2021-08-18 | Filing | ||
| $105.63 | 1,183 | 107,668 | 2021-08-17 | Filing | ||
| $73.75 | 4,557 | Director | 1,952,441 | 2020-09-09 | Filing | |
| $72.36 | 350 | Director | 5,800 | 2020-09-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $104.10 | 5,000 | 15,000 | 2022-05-09 | Filing | ||
| $134.46 | 40 | 24,970 | 2022-04-21 | Filing | ||
| $133.20 | 704 | 24,970 | 2022-04-20 | Filing | ||
| $130.81 | 3,500 | 24,970 | 2022-04-19 | Filing | ||
| $128.45 | 7,728 | 15,000 | 2022-04-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 243,226 | $30,838,626 | 0.01% | |
| 2. | 4,579,281 | $580,607 | 0.04% | |
| 3. | 2,912,872 | $369,323 | 52.91% | |
| 4. | 2,121,152 | $268,940 | 0% | |
| 5. | 2,111,234 | $267,683 | 0.02% |
News See All
Hedge Funds Are Crazy About Karuna Therapeutics, Inc. (KRTX)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is It Too Late to Buy Karuna Therapeutics (KRTX) Stock?
Miller Value Partners recently released its Q1 2021 Investor Letter, a copy of which you can download here.
Is KRTX A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Karuna Therapeutics, Inc. (NASDAQ:KRTX) is a good investment right now.
Hedge Funds Keep Buying Karuna Therapeutics, Inc. (KRTX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Have Never Been This Bullish On Karuna Therapeutics, Inc. (KRTX)
We hate to say this but, we told you so.
Is Karuna Therapeutics, Inc. (KRTX) A Good Stock To Buy ?
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its value at one point in 2018.
Hedge Fund and Insider Trading News: Anthony Scaramucci, Tangency Capital, Vermillion, Inc. (VRML), Xerox Corp (XRX), and More
Former White House communications director Anthony Scaramucci sees a landslide re-election for President Donald Trump in 2020, saying on Wednesday that voters will be wary of meddling with the success...
Billionaire Hedge Funds
